Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Allergy Therapeutics Takes First Steps Into Broader Vaccine Field

Licensing Agreement Signed With Saiba And DeepVax

Executive Summary

Allergy Therapeutics is keen to extend its early R&D pipeline into non-allergy areas through extending its tie-up with Saiba and DeepVax on their virus-like particle technology.

You may also be interested in...



Hanmi, Bioapp Accelerate Plant-Derived Coronavirus Vaccine

Hanmi is accelerating development of a plant-derived COVID-19 vaccine with Bioapp after successful early, the forming part of the leading South Korean pharma group’s post-pandemic business vision, which includes 'green biotech'.

Anergis And Virometix Collaborate On Fast-Acting Allergy Immunotherapy

An ultra-fast-acting allergy immunotherapy to induce tolerance to house dust mites is being sought in a collaboration between two Swiss biotechs, Anergis and Virometix.

Allergy Therapeutics Progresses Grass And Peanut Allergy Vaccines, Plans For US Entry

Clinical studies of grass allergy and peanut allergy vaccines are expected to start this year, as the UK specialty company plots its entry into the US.

Topics

Related Companies

UsernamePublicRestriction

Register

SC142906

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel